Search Results 531-540 of 16952 for ketamine

  1. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...

  2. Pharmacogenomics: Your Own Prescription - Mayo Clinic

    Each person's genetic code is unique. Researchers focused on pharmacogenomics at Mayo Clinic are working to understand how these tiny DNA variations cause ...

  3. A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor - Mayo Clinic

    About this study. This phase III trial compares memantine to usual treatment in treating patients with brain tumors that are newly diagnosed or has come ...

  4. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

    The purpose of this study is to assess the effect of vedolizumab subcutaneous (vedolizumab SC) as maintenance treatment in participants with moderately to ...

  5. A Study of Pharmacogenomics (PGx) Results and Clinical Data of Patients in the Palliative Medicine Clinic to Assess Current and Future Therapeutic Relevance - Mayo Clinic

    About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in ...

  6. Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH - Mayo Clinic

    This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH). It ...

  7. Mayo Clinic

    Share · Tweet . IMG-20480077. Home; cc-yoga-cobra_tablet. Fuel groundbreaking medical research! Give Today. Your donation powers the future of medicine and ...

  8. Shared Decision Making Occurrence Between Chronic Care Patients and Clinicians - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Migraine medications and antidepressants: A risky mix? - Mayo Clinic

    SSRIs and SNRIs raise serotonin levels. Triptans interact directly with some serotonin receptors in the brain. In theory, taking these medicines together could ...

  10. Clinical trials - Psychiatry and Psychology

    Mayo Clinic psychiatrists and psychologists are leaders in the clinical care of mental illnesses in people of all ages. They tailor their care to your exact ...